CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 194.05
+1.85 (0.96%)
Oct 19, 2026, 4:10 PM AEST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 92.93 billion as of October 16, 2026. It is the 378th most valuable company in the world and the 6th biggest in Australia. Its market cap has decreased by 12.00% in one year.
Market Cap
92.93B
Enterprise Value
108.68B
Revenue
22.83B
Global Rank
Country Rank
#6 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 92.93B, an increase of 29,686.47%. That is a compound annual growth rate of 19.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 92.93B | 11.64% |
| Dec 31, 2025 | 83.24B | -38.95% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.34B |
| Mesoblast | 2.58B |
| Neuren Pharmaceuticals | 2.56B |
| PYC Therapeutics | 1.88B |
| Clarity Pharmaceuticals | 695.80M |
| Clinuvel Pharmaceuticals | 381.23M |
| Starpharma Holdings | 359.80M |
| Tetratherix | 321.53M |